Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) Income from Continuing Operations: 2019-2024

Historic Income from Continuing Operations for LifeStance Health (LFST) over the last 5 years, with FY2024 value amounting to -$58.4 million.

  • LifeStance Health's Income from Continuing Operations rose 11807.96% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.1 million, marking a year-over-year increase of 8942.7%. This contributed to the annual value of -$58.4 million for FY2024, which is 6864.58% up from last year.
  • According to the latest figures from FY2024, LifeStance Health's Income from Continuing Operations is -$58.4 million, which was up 6864.58% from -$186.3 million recorded in FY2023.
  • LifeStance Health's 5-year Income from Continuing Operations high stood at -$58.4 million for FY2024, and its period low was -$307.2 million during FY2021.
  • Over the past 4 years, LifeStance Health's median Income from Continuing Operations value was -$200.9 million (recorded in 2022), while the average stood at -$191.9 million.
  • As far as peak fluctuations go, LifeStance Health's Income from Continuing Operations surged by 1359.32% in 2023, and later surged by 6864.58% in 2024.
  • Annual analysis of 4 years shows LifeStance Health's Income from Continuing Operations stood at -$307.2 million in 2021, then increased by 29.83% to -$215.6 million in 2022, then rose by 13.59% to -$186.3 million in 2023, then soared by 68.65% to -$58.4 million in 2024.
  • Its Income from Continuing Operations was -$58.4 million in FY2024, compared to -$186.3 million in FY2023 and -$215.6 million in FY2022.